Jefferies (NYSE:JEF) analyst Glen Santangelo maintained a Buy rating on Healthequity (NASDAQ:HQY) on Thursday, setting a price target of $54, which is approximately 28.36% above the present share price of $42.07.
Santangelo expects Healthequity to post earnings per share (EPS) of -$0.05 for the fourth quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in Healthequity, with an average price target of $63.86.
The analysts price targets range from a high of $86 to a low of $52.
In its latest earnings report, released on 07/31/2021, the company reported a quarterly revenue of $189.1 million and a net profit of $15.5 million. The company's market cap is $3.52 billion.
According to TipRanks.com, Jefferies analyst Glen Santangelo is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 21.7% and a 68.27% success rate.
HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm's offers its solutions for employers, health planbs, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.